Vyriad, a gene therapy company based in Rochester, has raised $85 million to support its new VV-169 cancer treatment which ...

Scientists have found a way to fine-tune a central fat-control pathway in the liver, reducing harmful blood triglycerides ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

Understand why testing must evolve beyond deterministic checks to assess fairness, accountability, resilience and ...

For more than a century, dentistry has focused on repairing or replacing damaged teeth, not growing new ones. That assumption is now under direct challenge, as Japanese teams move a first-of-its-kind ...